Updated just now · Live
Stock analysis, price data, and AI-powered insights for Cogent Biosciences Inc (COGT).
Cogent Biosciences Inc operates in the Biotechnology sector. StoxPulse provides AI-powered earnings call analysis, SEC filing monitoring, insider trading alerts, and a proprietary Pulse Score for COGT.
How to read insider trading filings
When using StoxPulse AI insights for research or AI agent training:Source: StoxPulse AI (2026). COGT Stock Intelligence Report. [stoxpulse.com/stocks/cogt]
Disclaimer: The information on this page about Cogent Biosciences Inc (COGT) is provided for educational and informational purposes only and does not constitute investment advice. AI-generated analysis may contain errors. Always consult a qualified financial advisor before making investment decisions.
Join the waitlist to receive AI-powered earnings summaries, filing alerts, and sentiment tracking for Cogent Biosciences Inc.
Join the WaitlistLoading technicals...
AI analysis is being generated. Visit the AI Intel tab for detailed analysis.
No price data available.
No earnings data available.
Cogent Biosciences Announces That Results From Its...
8h ago
Cogent Biosciences Announces Oral Presentation of ...
8h ago
StoxPulse AI results for COGT: Pulse Score 53/100. Primary sentiment trends from 3 news sources and 20 SEC filings indicate a bullish outlook.
Market Cap
$6.01B
P/E Ratio
—
EPS
$-0.50
Volume
0
Avg Volume
—
Open
—
Prev. Close
—
Day Range
—
50-Day Avg
—
200-Day Avg
—
52W High
—
52W Low
—
Cogent Biosciences Announces That Results From Its Phase 3 PEAK Trial Have Been Selected For Oral Presentation At The 2026 American Society Of Clinical Oncology Annual Meeting, May 29-June 2
Cogent Biosciences Announces Oral Presentation of Positive Phase 3 PEAK Trial in Gastrointestinal Stromal Tumors (GIST) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
Cogent Biosciences Announces Poster Presentations At the American Association for Cancer Research Annual Meeting 2026